Page last updated: 2024-08-25

methotrexate and Colitis Gravis

methotrexate has been researched along with Colitis Gravis in 145 studies

Research

Studies (145)

TimeframeStudies, this research(%)All Research%
pre-199010 (6.90)18.7374
1990's18 (12.41)18.2507
2000's31 (21.38)29.6817
2010's71 (48.97)24.3611
2020's15 (10.34)2.80

Authors

AuthorsStudies
Benkov, KJ; Colletti, RB; Crandall, W; Dotson, JL; Hunter, T; Komocsar, WJ; Liu, C; Steiner, SJ; Zhang, N1
Berger, T; Broekaert, IJ; Foeldvari, I; Geikowski, T; Horneff, G; Hospach, A; Hufnagel, M; Klein, A; Küster, M; Minden, K; Oommen, P; Quietzsch, J; Rogalski, B; Weller-Heinemann, F; Windschall, D1
Haq, SA; Momen Majumder, MS; Rasker, JJ1
Temtem, TA; Vickers, M; Whitworth, J1
Chhibba, T; Ma, C1
Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B1
Chevreau, J; Foulon, A; Fumery, M; Gondry, J; Yzet, C1
Gurney, ME; Kaelber, DC; Xu, R; Zhou, M1
Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, GG; Kuenzig, ME; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A; Zubieta, AA1
Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F1
Ahuja, V; Andoh, A; Chen, M; Han, DS; Hibi, T; Hilmi, IN; Hu, PJ; Jeen, YT; Kim, HJ; Leung, WK; Matsuoka, K; Ng, SC; Ooi, CJ; Qian, J; Ran, Z; Sollano, J; Suzuki, Y; Watanabe, M; Wei, SC; Wu, K; Yang, SK1
Heron, V; Loftus, EV1
Anikhindi, SA; Arora, A; Bansal, N; Gupta, P; Kumar, A; Sharma, P; Singla, V; Walinjkar, S1
Arai, D; Asakura, T; Betsuyaku, T; Ishii, M; Sugiura, H; Takei, H; Takeuchi, T1
Gouynou, C; Peyrin-Biroulet, L1
Dudler, J; Fournier, N; Michetti, P; Pittet, V; Rouiller-Braunschweig, C1
Jiang, X; Liao, W; Long, S; Lu, N; Shu, X; Zhu, X; Zhu, Z1
Long, MD; Vanga, R1
Bouma, G; de Boer, NKH; Dijkstra, G; Hoentjen, F; Meijer, B; Mulder, CJJ; Oldenburg, B; Ponsioen, CY; van Bodegraven, AA; van der Meulen, AE; van der Woude, CJ; Wintjens, DSJ1
Abraham, B; Anton, K; Barnes, EL; Cross, RK; Dryden, G; Fischer, M; Hanson, J; Harlan, W; Herfarth, H; Higgins, PDR; Isaacs, KL; Ivanova, A; Jackson, S; Levy, C; Lewis, JD; Long, MD; Martin, C; McCabe, R; Osterman, MT; Polyak, S; Saha, S; Sandler, RS; Sands, BE; Serrano, J; Valentine, JF; Williams, E; Yajnik, V1
Church, PC; de Ridder, L; Griffiths, AM; Hyams, J; Ruemmele, F; Turner, D1
Hanauer, SB; Lichtenstein, GR; Sandborn, WJ1
Dulai, PS1
Burns, C; Yetto, T1
Aviña, A; Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, G; Leung, S; Lix, L; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A1
Cohen, S; Galai, T; Moran-Lev, H; Yerushalmy-Feler, A1
Ainsworth, MA; Nielsen, OH; Steenholdt, C1
de Boer, NKH; Dijkstra, G; Hoentjen, F; Lissenberg-Witte, BI; Oldenburg, B; Pierik, M; Ponsioen, CY; Simsek, M; van der Meulen, AE; van der Woude, CJ; van Riswijk, MLM; Verschuren, S1
Bjerrum, JT; Herfarth, H; Nielsen, OH; Rogler, G1
Kane, SV; Yarur, A1
Abbas, AM; Balart, L; Khan, N; Moehlen, M1
Kiss, LS; Lakatos, PL; Mandel, M; Miheller, P1
Adedokun, OJ; Collins, J; Colombel, JF; Feagan, BG; Gibson, PR; Guzzo, C; Hibi, T; Järnerot, G; Johanns, J; Marano, C; Reinisch, W; Rutgeerts, P; Sandborn, WJ; Strauss, R; Zhang, H1
Adedokun, OJ; Collins, J; Colombel, JF; Feagan, BG; Gibson, PR; Guzzo, C; Järnerot, G; Johanns, J; Marano, C; Reinisch, W; Rutgeerts, P; Sandborn, WJ; Strauss, R; Zhang, H1
Lago, P; Magalhães, RK; Pedroto, I1
Mudter, J; Neurath, MF1
Arakawa, T; Fujiwara, Y; Fukushima, W; Hagihara, Y; Hirota, Y; Kamata, N; Maeda, K; Ohfuji, S; Shiba, M; Sogawa, M; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H1
Dubinsky, MC; Rabizadeh, S; Vahabnezhad, E1
Chande, N; MacDonald, JK; McDonald, JW; Wang, Y1
Sicilia, B1
Charro, M; Domènech, E; García-López, S; Gisbert, JP; Gomollón, F; Muñoz, F; Rubio, S1
Alves, VB; Basso, PJ; Bonfá, G; Cardoso, CR; Fonseca, MT; Nardini, V; Sales-Campos, H1
Ben-Horin, S; Bossuyt, P; Bouguen, G; Dotan, I; Jussila, A; Karmiris, K; Katsanos, KH; Kruis, W; Legido, J; Li, AC; Moreels, T; Naismith, GD; Preiss, JC; Scarcelli, A; Sorrentino, D; Steinwurz, F; Subramaniam, K; Tarabar, D; Yanai, H; Zaganas, IV1
Büning, J; Fellermann, K; Lehnert, H; Mackenroth, T; Möller, S; Olsen, V; Schmidt, KJ; Schröder, T; Sina, C1
El-Matary, W; Griffiths, AM; MacDonald, JK; Vandermeer, B; Wang, Y1
Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S1
Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH1
Abitbol, V; Allez, M; Bommelaer, G; Bossa, F; Bouhnik, Y; Bourreille, A; Brixi, H; Carbonnel, F; Colombel, JF; Coulibaly, B; Danese, S; Deplanque, D; Dewit, O; Färkkilä, M; Filippi, J; Fumery, M; Katsanos, KH; Laharie, D; Louis, E; Malamut, G; Michetti, P; Moreau, J; Nachury, M; Novacek, G; Peyrin-Biroulet, L; Reinisch, W; Roblin, X; Sarter, H; Seksik, P1
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R1
Herfarth, HH1
Afzali, A; Hu, JK; Lee, SD; Park, CJ; Sharma, P; Sinanan, MN; Zhu, K1
Ott, C1
Cottone, M; Macaluso, FS; Orlando, A; Renna, S1
Fernández-Bañares, F; Gisbert, JP1
Kobashigawa, T; Kotake, S; Nanke, Y; Yamanaka, H1
Grossman, AB; Maxwell, EC1
Annese, V; Deiana, S; Gabbani, T; Lunardi, S; Manetti, N1
Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G1
Achkar, JP; Brzezinski, A; Garber, A; Horton, N; Lashner, BA; Philpott, J; Shen, B; Wu, X1
Bar-Gil Shitrit, A; Ben-Horin, S; Chowers, Y; Eliakim, R; Engel, T; Fudim, E; Kopylov, U; Lang, A; Paul, S; Picard, O; Roblin, X; Ungar, B; Williet, N; Yavzori, M1
Cui, DJ; Hu, M; Yang, LC; Yang, XL1
Aicart, M; Alcaín, G; Almela, P; Arguelles-Arias, F; Arias-Rivera, ML; Barreiro-de Acosta, M; Barrio, J; Beltrán, B; Benítez, JM; Bermejo, F; Botella, B; Bujanda, L; Busquets, D; Calvet, X; Casanova, MJ; Castaño-Milla, C; Castro, E; Castro, L; Ceballos, D; Chaparro, M; Cortés, X; Domènech, E; Domínguez, M; Domínguez-Antonaya, M; Dueñas, C; Esteve, M; Fernández-Salazar, L; García-Herola, A; García-López, S; García-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Garrido, E; Gisbert, JP; Gómez-García, M; Gomollón, F; González-Lama, Y; Guardiola, J; Gutiérrez, A; Hernández-Martínez, A; Hervías, D; Hinojosa, J; Huguet, JM; Jauregui-Amezaga, A; Khorrami, S; Leo, E; Llaó, J; Lorente-Poyatos, R; Mañosa, M; Marín-Jiménez, I; Marrero, JM; Martín-Arranz, M; Martinez-Montiel, MP; Menacho, M; Merino, O; Monfort, D; Moraleja, I; Muñoz, C; Muñoz, F; Nantes, O; Navarro-Llavat, M; Novella, MT; Opio, V; Pajares, R; Pérez-Calle, JL; Pérez-Martínez, I; Pineda, JR; Ponferrada, A; Ramírez-de la Piscina, P; Ramos, L; Robles-Alonso, V; Rodríguez, C; Rodríguez, GE; Rodríguez-Pérez, A; Rojas-Feria, M; Roncedo, O; Sánchez-Torres, A; Sicilia, B; Taxonera, C; Tosca, J; Van Domselaar, M; Vázquez, JM; Vega-López, AB1
Agnholt, J1
Hutas, G1
Burakoff, R1
El-Matary, W; Griffiths, AM; Vandermeer, B1
Belaiche, J; Louis, E; Reenaers, C1
Herfarth, HH; Isaacs, KL; Lewis, JD; Osterman, MT; Sands, BE1
Bischoff, A1
Beaugerie, L; Carrat, F; Cosnes, J; Nion-Larmurier, I; Seksik, P; Sokol, H; Vienne, A1
Kane, S1
Aloi, M; Cavallari, N; Conte, F; Cucchiara, S; Di Nardo, G; Mazzeo, L; Nuti, F; Stronati, L1
de Francisco, R; Fernández-García, MS; García-Pravia, C; Gutiérrez-Corral, N; Riestra, S; Rodrigo, L; Rodríguez, JI; Rodríguez-Peláez, M1
Deslandres, C; Noble, A; Willot, S1
Ford, AC; Hamlin, PJ; Jackson, EL1
Dubinsky, MC; Ford, AC; Khan, KJ; Moayyedi, P; Talley, NJ; Ullman, TA1
Carbonnel, F1
Gudkova, RB; Khomeriki, SG; Kniazev, OV; Konopliannikov, AG; Konopliannikova, OA; Lazebnik, LB; Mikhaĭlova, ZF; Parfenov, AI; Rogozina, VA; Ruchkina, IN; Shcherbakov, PL; Tsaregorodtseva, TM1
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C1
Aguas, M; Barreiro-de Acosta, M; Carpio, D; Castro, L; Chaparro, M; García, V; García-Bosch, O; Mañosa, M1
Bell, SJ; Brown, SJ; Chan, FK; Chan, H; Chow, DK; Connell, WR; De Cruz, P; Desmond, PV; Kamm, MA; Leong, RW; Lust, M; Ng, SC; Prideaux, L; Sung, JJ; Williams, J; Wu, JC1
Algaba, A; Barbero-Villares, A; Bermejo, F; Gisbert, JP; López-Sanromán, A; Maté, J; Mendoza Jiménez-Ridruejo, J; Mendoza, JL; Moreno-Otero, R; Pajares, R; Pérez-Calle, JL; Taxonera, C1
Kiss, SL; Lakatos, PL; Lorinczy, K; Miheller, P1
Limdi, JK; Muhammad, R; Wong, CL1
Boyle, B; Colletti, RB; Crandall, WV; Kappelman, MD; King, E; Lee, GJ; Pratt, JM1
Makol, A; Sokumbi, O; Warrington, KJ; Wetter, DA1
Kim, HS; Kim, YS; Lee, J1
Ammendola, A; Diculescu, M; Dietrich, B; Fellermann, K; Hartmann, H; Hentsch, B; Herrlinger, KR; Howaldt, S; Nikolov, R; Otte, JM; Petrov, A; Reindl, W; Stange, EF; Stoynov, S; Strauch, U; Sturm, A; Voiosu, R1
Herfarth, HH; Isaacs, KL; Long, MD1
Crispino, P; Iacopini, F; Iannoni, C; Marcheggiano, A; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M1
Alstead, EM; Nelson-Piercy, C1
Göke, B; Ochsenkühn, T; Sackmann, M1
Folwaczny, C; Siveke, JT1
Fraser, AG1
Schröder, O; Stein, J2
GOLDGRABER, MB; KIRSNER, JB1
Hanioka, K; Maeda, A; Matsushita, A; Nagai, K; Sugimoto, N; Takahashi, T; Watanabe, N1
Ansari, A; Hirst, J; Raoof, S; Sanderson, JD; Soon, SY; Yaneza, M1
Iacopini, F; Paoluzi, OA; Paoluzi, P; Pica, R1
Dignass, AU; Herrlinger, K; Schölmerich, J1
Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H1
Stiefelhagen, P1
Herrlinger, K; Stange, EF1
Cummings, JR; Gorard, DA; Herrlinger, KR; Jewell, DP; McIntyre, AS; Travis, SP1
Ahmad, T; Barnardo, MC; Cummings, JR; Herrlinger, KR; Jewell, DP; Schwab, M1
Barta, Z; Tóth, L; Zeher, M1
Amezcua-Guerra, LM; Bojalil, R; Hernández-Martínez, B; Pineda, C1
Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R1
Gibson, PR; Iser, JH; Nathan, DM1
Chande, N; MacDonald, JK; McDonald, JW1
Chalumeau, S; Claudel-Bonvoisin, S; Flourié, B; Moussata, D; Nancey, S; Saurin, JC1
Atherton, LD; Kaye, MD; Leib, ES1
Korelitz, BI1
Driessen, WM; Houben, MH; van Spreeuwel, JP; van Wijk, HJ1
van Hogezand, RA1
Baratz, M; Gilat, T; Hallak, A; Halpern, Z; Rabau, M; Santo, M; Werbin, N1
Baron, TH; Elson, CO; Truss, CD1
Daum, F; Grancher, K; Mandel, F; Markowitz, J1
Chakravarty, BJ1
Arber, N; Bardan, E; Broide, E; Eliakim, R; Fich, A; Gilat, T; Keter, D; Lavy, A; Moshkowitz, M; Odes, S; Oren, R; Patz, J; Pomeranz, I; Reisfeld, I; Ron, Y; Villa, Y1
Kozarek, RA1
Lichtenstein, GR; Stotland, BR1
Schölmerich, J1
Modigliani, R1
Baert, F; Rutgeerts, P1
Hanauer, SB; Stein, RB1
Kougo, Y1
Egan, LJ; Leighton, JA; Lipsky, JJ; Mays, DC; Pike, MG; Sandborn, WJ; Tremaine, WJ; Zinsmeister, AR1
Faubion, WA; Sandborn, WJ1
Baker, AL; Conjeevaram, HS; Hanauer, SB; Kuan, SF; Schiano, TD; Te, HS1
Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ1
DiPiro, JT; Vandell, AG1
Cerný, K; Krajcí, A; Uvízi, J1
Kessinger, A; Novak, RA1
Belaiche, J; Delwaide, J; Gast, P; Louis, E1
Ball, TJ; Botoman, VA; Gelfand, MD; Kozarek, RA; Patterson, DJ; Wilske, KR1
Schwartz, RS; Swanson, MA1
Scheiffarth, F; Warnatz, H1
Moeschlin, S1
Schwartz, RS; Skinner, MD1

Reviews

46 review(s) available for methotrexate and Colitis Gravis

ArticleYear
Is there room for immunomodulators in ulcerative colitis?
    Expert opinion on biological therapy, 2020, Volume: 20, Issue:4

    Topics: Clinical Trials as Topic; Colitis, Ulcerative; Gastrointestinal Diseases; Humans; Immunologic Factors; Methotrexate; Purines; Severity of Illness Index; Treatment Outcome

2020
[IBD and pregnancy: From conception to birth].
    Gynecologie, obstetrique, fertilite & senologie, 2020, Volume: 48, Issue:6

    Topics: Cesarean Section; Colitis, Ulcerative; Crohn Disease; Delivery, Obstetric; Female; Fertilization; Fetus; Gestational Age; Humans; Infant, Newborn; Infertility; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thalidomide

2020
Inflammatory Bowel Disease - Non-biological treatment.
    Pharmacological research, 2020, Volume: 160

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome

2020
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:3

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Asia; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Female; Gastroenterology; Humans; Immunosuppressive Agents; Male; Methotrexate; Monitoring, Physiologic; Pacific Islands; Practice Guidelines as Topic; Pregnancy; Remission Induction; Societies, Medical; Tuberculosis, Gastrointestinal

2021
Nonbiologic Immune Suppression in Ulcerative Colitis.
    Gastroenterology clinics of North America, 2020, Volume: 49, Issue:4

    Topics: Azathioprine; Colitis, Ulcerative; Contraindications, Drug; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Meta-Analysis as Topic; Methotrexate; Piperidines; Pyrimidines; Remission Induction

2020
Contemporary Management of Ulcerative Colitis.
    Current gastroenterology reports, 2018, Mar-27, Volume: 20, Issue:3

    Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Drug Monitoring; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor-alpha

2018
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Gastroenterology, 2019, Volume: 156, Issue:1

    Topics: Anti-Inflammatory Agents; Azathioprine; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Mercaptopurine; Methotrexate; Purines; Risk Factors; Thioguanine; Treatment Outcome

2019
Recent advances using immunomodulators for inflammatory bowel disease.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:6

    Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate

2013
Update on pregnancy and breastfeeding in the era of biologics.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Volume: 45, Issue:10

    Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus

2013
Methotrexate: should we start using it in clinical practice?
    Current drug targets, 2013, Volume: 14, Issue:12

    Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction

2013
[Treatment of chronic inflammatory bowel disease based on evidence and according to stage: top down].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:36

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Medical Intervention; Evidence-Based Medicine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome

2013
Methotrexate for induction of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2014, Aug-27, Issue:8

    Topics: Administration, Oral; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Induction Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Randomized Controlled Trials as Topic

2014
Classical and recent advances in the treatment of inflammatory bowel diseases.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2015, Volume: 48, Issue:2

    Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell- and Tissue-Based Therapy; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Microbiota; Probiotics; Purines; Quality of Life; Tumor Necrosis Factor-alpha

2015
Methotrexate for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2015, Aug-11, Issue:8

    Topics: Administration, Oral; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Sulfasalazine

2015
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
    Inflammatory bowel diseases, 2015, Volume: 21, Issue:12

    Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention

2015
Methotrexate for Inflammatory Bowel Diseases - New Developments.
    Digestive diseases (Basel, Switzerland), 2016, Volume: 34, Issue:1-2

    Topics: Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Methotrexate; Treatment Outcome; Tumor Necrosis Factor-alpha

2016
Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Inflammatory bowel diseases, 2016, Volume: 22, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Odds Ratio; Postoperative Complications; Preoperative Period; Retrospective Studies; Sepsis; Tumor Necrosis Factor-alpha; Young Adult

2016
Advances in Pediatric Inflammatory Bowel Disease.
    Adolescent medicine: state of the art reviews, 2016,Spring, Volume: 27, Issue:1

    Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus

2016
Safety profile of methotrexate in inflammatory bowel disease.
    Expert opinion on drug safety, 2016, Volume: 15, Issue:10

    Topics: Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Steroids

2016
Methotrexate for maintenance of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Administration, Oral; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction

2009
Efficacy of methotrexate in ulcerative colitis: failure or promise.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Colitis, Ulcerative; Female; Folic Acid Antagonists; Humans; Male; Methotrexate; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome

2010
Preparing the patient for immunosuppressive therapy.
    Current gastroenterology reports, 2010, Volume: 12, Issue:6

    Topics: Algorithms; Colitis, Ulcerative; Counseling; Crohn Disease; Glucocorticoids; Humans; Immunization Schedule; Immunosuppressive Agents; Medical History Taking; Mercaptopurine; Methotrexate; Methyltransferases; Patient Selection; Tumor Necrosis Factor-alpha

2010
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    The American journal of gastroenterology, 2011, Volume: 106, Issue:4

    Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intramuscular; Mercaptopurine; Methotrexate; Remission Induction; Secondary Prevention; Treatment Failure

2011
Methotrexate: a drug of the future in ulcerative colitis?
    Current drug targets, 2011, Volume: 12, Issue:10

    Topics: Clinical Trials as Topic; Colitis, Ulcerative; Humans; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies

2011
[Epidemiology, predictors and clinical aspects of loss of response to biological therapy].
    Orvosi hetilap, 2012, Feb-05, Volume: 153, Issue:5

    Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Drug Tolerance; Gastrointestinal Agents; Humans; Immunologic Factors; Immunotherapy; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors; Treatment Failure; Tumor Necrosis Factor-alpha

2012
Methotrexate: underused and ignored?
    Digestive diseases (Basel, Switzerland), 2012, Volume: 30 Suppl 3

    Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Methotrexate; Patient Preference; Treatment Outcome

2012
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Der Radiologe, 2003, Volume: 43, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Cyclosporins; Diagnosis, Differential; Gastrointestinal Agents; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Meta-Analysis as Topic; Methotrexate; Parenteral Nutrition; Prednisolone; Quality of Life; Time Factors; Ultrasonography

2003
Methotrexate: first-line or second-line immunomodulator?
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:3

    Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Liver Cirrhosis; Methotrexate

2003
Low dose methotrexate in inflammatory bowel disease: current status and future directions.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Randomized Controlled Trials as Topic; Treatment Outcome

2003
[Chronic inflammatory bowel diseases].
    Deutsche medizinische Wochenschrift (1946), 2004, Oct-15, Volume: 129, Issue:42

    Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography

2004
Pharmacogenetics in inflammatory bowel disease.
    World journal of gastroenterology, 2006, Jun-21, Volume: 12, Issue:23

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome

2006
Methotrexate for induction of remission in ulcerative colitis.
    The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4

    Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Methotrexate; Remission Induction

2007
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    The Gastroenterologist, 1995, Volume: 3, Issue:2

    Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; History, 20th Century; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications

1995
Medical management of patients with difficult-to-treat inflammatory bowel disease.
    The Netherlands journal of medicine, 1994, Volume: 45, Issue:2

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole

1994
Newer treatments for inflammatory bowel disease.
    Primary care, 1996, Volume: 23, Issue:3

    Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena

1996
Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:9

    Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-10; Mercaptopurine; Methotrexate

1997
Drug therapy for ulcerative colitis during pregnancy.
    European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:9

    Topics: Adrenal Cortex Hormones; Antidiarrheals; Azathioprine; Breast Feeding; Colitis, Ulcerative; Cyclosporine; Female; Humans; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine

1997
Medical therapy for inflammatory bowel disease.
    Gastroenterology clinics of North America, 1999, Volume: 28, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids

1999
[Recent progress in therapy of inflammatory bowel diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids

1999
Clinical pharmacology of inflammatory bowel disease therapies.
    Current gastroenterology reports, 2000, Volume: 2, Issue:6

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Methotrexate; Pharmacogenetics; Receptors, Glucocorticoid

2000
Maintenance drugs for inflammatory bowel disease.
    Drug and therapeutics bulletin, 2001, Volume: 39, Issue:12

    Topics: Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Infliximab; Methotrexate; Treatment Outcome

2001
Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.
    Pharmacotherapy, 2002, Volume: 22, Issue:5

    Topics: Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Secondary Prevention

2002
[Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings].
    Revue medicale de Liege, 1992, Volume: 47, Issue:11

    Topics: Antineoplastic Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Methotrexate

1992
Cytotoxic drugs in treatment of nonmalignant diseases.
    Annals of internal medicine, 1972, Volume: 76, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Granulomatosis with Polyangiitis; Hepatitis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Infections; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Ophthalmia, Sympathetic; Psoriasis; Thioguanine; Uveitis

1972
[Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
    Deutsche medizinische Wochenschrift (1946), 1969, Nov-21, Volume: 94, Issue:47

    Topics: Adrenocorticotropic Hormone; Alkylating Agents; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Colitis, Ulcerative; Cyclophosphamide; Humans; Immunosuppressive Agents; Liver Cirrhosis; Lupus Erythematosus, Systemic; Methotrexate; Nephritis; Thrombocytopenia; Time Factors

1969
Immunosuppressive therapy. 1.
    The New England journal of medicine, 1972, Aug-03, Volume: 287, Issue:5

    Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic

1972

Trials

14 trial(s) available for methotrexate and Colitis Gravis

ArticleYear
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
    Gastroenterology, 2018, Volume: 155, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Steroids; Time Factors; Treatment Outcome; United States

2018
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Gastroenterology, 2014, Volume: 146, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Middle Aged; Quality of Life; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha

2014
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
    Gastroenterology, 2014, Volume: 146, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha

2014
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
    Gastroenterology, 2016, Volume: 150, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Gastrointestinal Agents; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Methotrexate; Middle Aged; Remission Induction; Time Factors; Treatment Outcome; Wound Healing

2016
[Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:11

    Topics: Adult; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Stromal Cells; Transplantation, Homologous

2010
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:8

    Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biphenyl Compounds; Blood Sedimentation; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Feces; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Intention to Treat Analysis; Leukocyte L1 Antigen Complex; Male; Methotrexate; Middle Aged; Oxidoreductases Acting on CH-CH Group Donors; Prednisolone; Remission Induction; Severity of Illness Index; Young Adult

2013
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:10

    Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Single-Blind Method; Treatment Outcome

2002
Pulse cyclophosphamide therapy for inflammatory bowel disease.
    World journal of gastroenterology, 2006, Feb-28, Volume: 12, Issue:8

    Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Pulse Therapy, Drug; Remission Induction

2006
[Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease].
    Nederlands tijdschrift voor geneeskunde, 1994, Dec-17, Volume: 138, Issue:51

    Topics: Adolescent; Adult; Colitis; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Female; Humans; Ileitis; Male; Methotrexate; Middle Aged; Treatment Outcome

1994
Low-dose oral methotrexate in refractory inflammatory bowel disease.
    Digestive diseases and sciences, 1993, Volume: 38, Issue:10

    Topics: Administration, Oral; Adult; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Pilot Projects; Prednisone; Time Factors; Treatment Outcome

1993
Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial.
    Gastroenterology, 1996, Volume: 110, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Chronic Disease; Colitis, Ulcerative; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Israel; Male; Methotrexate; Middle Aged; Remission Induction

1996
[Methotrexate in therapy of chronic inflammatory bowel diseases].
    Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:7

    Topics: Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Intestinal Mucosa; Methotrexate; Prednisone; Prospective Studies

1996
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:12

    Topics: Adult; Aged; Antirheumatic Agents; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Inflammation; Male; Methotrexate; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome

1999
Immunosuppressive therapy. 1.
    The New England journal of medicine, 1972, Aug-03, Volume: 287, Issue:5

    Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic

1972

Other Studies

86 other study(ies) available for methotrexate and Colitis Gravis

ArticleYear
Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease.
    Current medical research and opinion, 2023, Volume: 39, Issue:1

    Topics: Adalimumab; Biological Factors; Biological Products; Child; Colitis, Ulcerative; Crohn Disease; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor Inhibitors

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Disease; Etanercept; Humans; Inflammatory Bowel Diseases; Leflunomide; Methotrexate; Retrospective Studies; Sulfasalazine

2023
Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports.
    Journal of medical case reports, 2023, Mar-01, Volume: 17, Issue:1

    Topics: Adult; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Sulfasalazine

2023
Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
    Nutrients, 2023, Mar-24, Volume: 15, Issue:7

    Topics: Adolescent; Adult; Child; Child, Preschool; Colitis, Ulcerative; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Young Adult

2023
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
    Ocular immunology and inflammation, 2020, Nov-16, Volume: 28, Issue:8

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage

2020
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
    PloS one, 2020, Volume: 15, Issue:3

    Topics: Adalimumab; Adolescent; Adult; Aged; Alzheimer Disease; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Case-Control Studies; Colitis, Ulcerative; Etanercept; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk; Tumor Necrosis Factor Inhibitors; Young Adult

2020
Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
    Gastroenterology, 2020, Volume: 158, Issue:5

    Topics: Adult; Ambulatory Care; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Decision Support Techniques; Drug Therapy, Combination; Humans; Immunologic Factors; Methotrexate; Piperidines; Practice Guidelines as Topic; Pyrimidines; Pyrroles; Severity of Illness Index

2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
    Journal of Crohn's & colitis, 2020, Oct-05, Volume: 14, Issue:10

    Topics: Adalimumab; Adult; Azathioprine; Biological Products; Canada; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Infliximab; Male; Methotrexate; Outcome and Process Assessment, Health Care; Patient Selection; Practice Patterns, Physicians'; Treatment Failure; Tumor Necrosis Factor Inhibitors

2020
Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report.
    Indian journal of pathology & microbiology, 2021, Volume: 64, Issue:Supplement

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biopsy; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Treatment Outcome

2021
Pulmonary Cryptococcosis Developed from a Nodule after Treatment with Infliximab for Arthritis Associated with Ulcerative Colitis.
    Annals of the American Thoracic Society, 2017, Volume: 14, Issue:4

    Topics: Aged; Antifungal Agents; Arthritis; Colitis, Ulcerative; Cryptococcosis; Humans; Immunocompromised Host; Infliximab; Lung; Lung Diseases, Fungal; Male; Methotrexate; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha

2017
Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab-treated patients.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Humans; Methotrexate

2017
Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Digestion, 2017, Volume: 96, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Intestinal Mucosa; Longitudinal Studies; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Wound Healing; Young Adult

2017
Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report.
    Medicine, 2018, Volume: 97, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Behcet Syndrome; Colitis, Ulcerative; Colonoscopy; Gastrointestinal Tract; Glucocorticoids; Humans; Male; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome

2018
Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.
    Inflammatory bowel diseases, 2018, 06-08, Volume: 24, Issue:7

    Topics: Adult; Colitis, Ulcerative; Databases, Factual; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Netherlands; Proportional Hazards Models; Prospective Studies; Remission Induction; Thioguanine; Treatment Outcome

2018
The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World.
    Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018

    Topics: Adalimumab; Adolescent; Africa; Asia; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Europe; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infliximab; Internationality; Methotrexate; North America; Oceania; Practice Patterns, Physicians'; South America; Surveys and Questionnaires; Tumor Necrosis Factor-alpha

2018
Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
    Gastroenterology, 2018, Volume: 155, Issue:4

    Topics: Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction

2018
Linear IgA bullous dermatosis associated with ulcerative proctitis: treatment challenge.
    Dermatology online journal, 2018, Jul-15, Volume: 24, Issue:7

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Linear IgA Bullous Dermatosis; Male; Mesalamine; Methotrexate; Methylprednisolone; Middle Aged; Proctitis; Retreatment

2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:9

    Topics: Adalimumab; Adult; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Digestive System Surgical Procedures; Drug Substitution; Drug Therapy, Combination; Female; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Male; Manitoba; Methotrexate; Prednisone; Proportional Hazards Models; Retrospective Studies; Tumor Necrosis Factor Inhibitors

2019
Predictors for Complicated Disease Course after Stepping Down from Combination to Antitumor Necrosis Factor Alpha Monotherapy in Children with Inflammatory Bowel Disease.
    Digestion, 2020, Volume: 101, Issue:2

    Topics: Adalimumab; Adolescent; Child; Colitis, Ulcerative; Crohn Disease; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Purines; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Necrosis Factor Inhibitors

2020
Methotrexate for inflammatory bowel disease: time for reconsideration.
    Expert review of gastroenterology & hepatology, 2019, Volume: 13, Issue:5

    Topics: Anti-Inflammatory Agents; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Methotrexate; Patient Selection; Remission Induction; Treatment Outcome

2019
Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:10

    Topics: Adolescent; Adult; Allopurinol; Beclomethasone; Colitis, Ulcerative; Crohn Disease; Databases, Factual; Female; Humans; Male; Mercaptopurine; Methotrexate; Netherlands; Off-Label Use; Thioguanine; Young Adult

2019
Methotrexate in ulcerative colitis: a nationwide retrospective cohort from the Veterans Affairs Health Care System.
    Inflammatory bowel diseases, 2013, Volume: 19, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colitis, Ulcerative; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; United States; United States Department of Veterans Affairs; Veterans; Young Adult

2013
Treatment of inflammatory bowel disease with methotrexate in clinical practice.
    Journal of Crohn's & colitis, 2013, Volume: 7, Issue:11

    Topics: Adult; Aged; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Patient Safety; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2013
Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Viral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunity, Active; Immunosuppressive Agents; Infliximab; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Tacrolimus

2014
A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.
    Inflammatory bowel diseases, 2014, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antibodies, Monoclonal; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Remission Induction; Retrospective Studies; Tertiary Care Centers; Time Factors; Treatment Failure; Young Adult

2014
[No best treatment for severe outbreaks: Maintenance, the key in colitis].
    Gastroenterologia y hepatologia, 2011, Volume: 34 Suppl 3

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Disease Management; Disease Progression; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Patient Preference; Practice Patterns, Physicians'; Salicylates; Tumor Necrosis Factor-alpha

2011
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:1

    Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Nausea; Ondansetron

2015
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Journal of Crohn's & colitis, 2015, Volume: 9, Issue:5

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cerebrovascular Disorders; Certolizumab Pegol; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Rare Diseases; Retreatment; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult

2015
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
    European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Body Mass Index; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Fatty Liver; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Ultrasonography; Young Adult

2015
Thromboembolism as an important complication of inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1

    Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis

2016
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
    The New Zealand medical journal, 2015, Oct-16, Volume: 128, Issue:1423

    Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha

2015
[News on the impact of Methotrexate as therapeutic option in patients with ulcerative colitis].
    Zeitschrift fur Gastroenterologie, 2016, Volume: 54, Issue:5

    Topics: Colitis, Ulcerative; Humans; Immunosuppressive Agents; Methotrexate

2016
The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?
    Gastroenterology, 2016, Volume: 151, Issue:1

    Topics: Colitis, Ulcerative; Humans; Immunosuppressive Agents; Methotrexate

2016
Letter: oral low-dose methotrexate for collagenous colitis - authors' reply.
    Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:1

    Topics: Colitis, Collagenous; Colitis, Ulcerative; Humans; Methotrexate

2016
A case of enteropathic arthritis successfully treated with methotrexate.
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2016, Volume: 39, Issue:3

    Topics: Adult; Arthritis; Colitis, Ulcerative; Humans; Male; Methotrexate; Treatment Outcome

2016
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:10

    Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha

2016
Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:11

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Child; Cohort Studies; Colectomy; Colitis, Ulcerative; Colonic Pouches; Crohn Disease; Digestive System Surgical Procedures; Enterostomy; Female; Hospitalization; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Methotrexate; Proctocolectomy, Restorative; Prognosis; Retrospective Studies; Young Adult

2016
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
    Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:2

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies; Antibody Formation; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunologic Factors; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Young Adult

2017
Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflammatory bowel diseases, 2017, Volume: 23, Issue:1

    Topics: Colitis, Ulcerative; Humans; Inflammatory Bowel Diseases; Methotrexate

2017
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    The American journal of gastroenterology, 2017, Volume: 112, Issue:1

    Topics: Adalimumab; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Colitis, Ulcerative; Colon; Constriction, Pathologic; Crohn Disease; Deprescriptions; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ileum; Immunologic Factors; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult

2017
[Biological therapy as treatment of inflammatory bowel diseases].
    Ugeskrift for laeger, 2008, Jun-09, Volume: 170, Issue:24

    Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome

2008
Golimumab, a fully human monoclonal antibody against TNFalpha.
    Current opinion in molecular therapeutics, 2008, Volume: 10, Issue:4

    Topics: Adult; Animals; Antibodies, Monoclonal; Arthritis, Rheumatoid; Asthma; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha

2008
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
    Inflammatory bowel diseases, 2008, Volume: 14 Suppl 2

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome

2008
Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination?
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:8

    Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Corticosterone; Crohn Disease; Female; Gastrointestinal Agents; Humans; Infliximab; Latent Tuberculosis; Male; Methotrexate; Radiography; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha

2010
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
    MMW Fortschritte der Medizin, 2010, Jan-14, Volume: 152, Issue:1-2

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction

2010
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
    Gut, 2010, Volume: 59, Issue:10

    Topics: Adult; Aged; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate; Prospective Studies; Registries; Tumor Necrosis Factor-alpha; Young Adult

2010
Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre.
    Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Child; Colitis, Ulcerative; Female; Humans; Longitudinal Studies; Male; Methotrexate; Remission Induction; Retrospective Studies

2010
Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:5

    Topics: Aged; Colitis, Ulcerative; Colonic Neoplasms; Herpesvirus 8, Human; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Opportunistic Infections; Prednisone; Sarcoma, Kaposi

2010
Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Inflammatory bowel diseases, 2011, Volume: 17, Issue:12

    Topics: Adolescent; Canada; Child; Child, Preschool; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Maximum Tolerated Dose; Methotrexate; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome

2011
VSL#3 and remission in active ulcerative colitis: larger studies required.
    The American journal of gastroenterology, 2011, Volume: 106, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Diet; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lactobacillus; Mesalamine; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Severity of Illness Index

2011
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
    Journal of Crohn's & colitis, 2011, Volume: 5, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus

2011
Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy.
    Journal of Crohn's & colitis, 2011, Volume: 5, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retrospective Studies; Spain; Treatment Outcome

2011
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Age Factors; Anal Canal; Analysis of Variance; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Constriction, Pathologic; Crohn Disease; Cyclosporine; Female; Hong Kong; Hospitalization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Sex Factors; Smoking; Steroids; Tumor Necrosis Factor Inhibitors; Victoria; Young Adult

2012
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial.
    Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:5

    Topics: Adult; Analysis of Variance; Chi-Square Distribution; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Elasticity Imaging Techniques; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis; Logistic Models; Male; Methotrexate; Middle Aged

2012
Vaccinating patients with inflammatory bowel disease--primum non nocere.
    Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:8-9

    Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Female; Guideline Adherence; Humans; Immunosuppressive Agents; Infliximab; Male; Mass Screening; Methotrexate; Middle Aged; Practice Guidelines as Topic; Prednisolone; Vaccination

2012
Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease.
    Journal of pediatric gastroenterology and nutrition, 2012, Volume: 55, Issue:6

    Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Body Height; Body Mass Index; Child; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Female; Growth; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Severity of Illness Index; Sex Factors; Treatment Outcome

2012
Vasculitis associated with tumor necrosis factor-α inhibitors.
    Mayo Clinic proceedings, 2012, Volume: 87, Issue:8

    Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Etanercept; Female; Glucocorticoids; Hematuria; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyneuropathies; Prednisone; Proteinuria; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rituximab; Tumor Necrosis Factor-alpha; Vasculitis; Young Adult

2012
Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis.
    Rheumatology international, 2013, Volume: 33, Issue:11

    Topics: Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphosphonates; Drug Therapy, Combination; Humans; Male; Methotrexate; Osteomyelitis; Pamidronate; Recurrence; Treatment Outcome

2013
Inflammatory bowel disease in pregnancy.
    Gut, 2003, Volume: 52, Issue:2

    Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Steroids; Sulfasalazine

2003
Methotrexate in ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:3

    Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Methotrexate

2003
Inducing remission in inflammatory bowel disease.
    Drug and therapeutics bulletin, 2003, Volume: 41, Issue:4

    Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction

2003
CARCINOMA OF THE COLON IN ULCERATIVE COLITIS.
    Cancer, 1964, Volume: 17

    Topics: Aged; Aging; Cell Biology; Colitis; Colitis, Ulcerative; Colonic Neoplasms; Fluorouracil; Humans; Mechlorethamine; Methotrexate; Neoplasms; Pathology; Polyps; Radiography; Surgical Procedures, Operative

1964
Association of intestinal malignant lymphoma and ulcerative colitis.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Colonoscopy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma; Methotrexate; Peripheral Blood Stem Cell Transplantation; Sigmoid Neoplasms; Vincristine

2003
Experience with the use of low-dose methotrexate for inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Aged; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome

2004
Low-dose methotrexate in ulcerative colitis: still a matter of debate.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Colitis, Ulcerative; Drug Administration Schedule; Humans; Immunosuppressive Agents; Methotrexate

2004
[Ulcerative colitis. Chronic active course].
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9

    Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Disease; Ciprofloxacin; Colectomy; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Diabetes Mellitus; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena; Pregnancy; Recurrence; Remission Induction; Risk Factors; Time Factors

2004
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9

    Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors

2004
[Immunosuppressed patient becomes pregnant. Termination of pregnancy unavoidable?].
    MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28

    Topics: Abortion, Eugenic; Colitis, Ulcerative; Contraindications; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Complications; Risk Factors

2004
Oral methotrexate in ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2005, Feb-15, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome

2005
The pharmacogenetics of methotrexate in inflammatory bowel disease.
    Pharmacogenetics and genomics, 2005, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; DNA; Female; gamma-Glutamyl Hydrolase; Genetic Predisposition to Disease; Genotype; Humans; Male; Maximum Tolerated Dose; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein; Transcription Factors; Treatment Outcome

2005
Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis.
    Gut, 2006, Volume: 55, Issue:7

    Topics: Abatacept; Antirheumatic Agents; Arthritis, Rheumatoid; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Immunoconjugates; Male; Methotrexate; Middle Aged

2006
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Medical Records; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome

2008
[Pancytopenia induced by two low-dose injections of methotrexate in a patient treated for ulcerative colitis].
    Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:12

    Topics: Aged; Colitis, Ulcerative; Folic Acid Antagonists; Humans; Hypoalbuminemia; Immunosuppressive Agents; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Methotrexate; Pancytopenia; Proctocolitis; Renal Insufficiency; Risk Factors; Sepsis

2007
Toxic megacolon associated with methotrexate therapy.
    Gastroenterology, 1984, Volume: 86, Issue:6

    Topics: Colitis, Ulcerative; Colon; Female; Humans; Megacolon, Toxic; Methotrexate; Middle Aged; Psoriasis

1984
Ileitis after colectomy for ulcerative colitis or carcinoma.
    Gut, 1994, Volume: 35, Issue:3

    Topics: Adult; Aged; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Female; Humans; Ileitis; Ileum; Male; Mesalamine; Methotrexate; Middle Aged; Postoperative Complications

1994
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    The American journal of gastroenterology, 1993, Volume: 88, Issue:1

    Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires

1993
Predictors and the rate of medical treatment failure in ulcerative colitis.
    The American journal of gastroenterology, 1993, Volume: 88, Issue:6

    Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Discriminant Analysis; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Risk Factors; Steroids; Treatment Failure

1993
Methotrexate and ulcerative colitis: wrong drug? Wrong dose? Or wrong disease?
    Gastroenterology, 1996, Volume: 110, Issue:5

    Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Prednisone

1996
Immunomodulator therapy of inflammatory bowel disease.
    Acta clinica Belgica, 1997, Volume: 52, Issue:5

    Topics: Antimetabolites, Antineoplastic; Azathioprine; Blood Component Removal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate

1997
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:11

    Topics: Adult; Biopsy; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Female; Folic Acid Antagonists; Humans; Liver; Male; Methotrexate; Time Factors

2000
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
    Inflammatory bowel diseases, 2000, Volume: 6, Issue:4

    Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome

2000
[Acute necrotizing colitis in a psoriatic treated by methotrexát (author's transl)].
    Ceskoslovenska dermatologie, 1977, Volume: 52, Issue:4

    Topics: Adult; Colitis, Ulcerative; Female; Humans; Methotrexate; Necrosis; Psoriasis

1977
Methotrexate induced colitis.
    The Nebraska medical journal, 1976, Volume: 61, Issue:3

    Topics: Colitis, Ulcerative; Female; Humans; Methotrexate; Middle Aged; Radiography

1976
Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.
    Annals of internal medicine, 1989, Mar-01, Volume: 110, Issue:5

    Topics: Colitis, Ulcerative; Colonoscopy; Crohn Disease; Humans; Methotrexate; Parenteral Nutrition, Total; Prednisone; Sigmoidoscopy

1989
Immunosuppressive therapy. The relation between clinical response and immunologic competence.
    The New England journal of medicine, 1967, Jul-27, Volume: 277, Issue:4

    Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibody Formation; Azathioprine; Chronic Disease; Colitis, Ulcerative; Female; gamma-Globulins; Hemagglutination Tests; Hemocyanins; Humans; Hypersensitivity, Delayed; Isoantibodies; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Myositis; Nephrotic Syndrome; Purpura, Thrombocytopenic; Skin Tests

1967
[Treatment of autoimmune diseases].
    Schweizerische medizinische Wochenschrift, 1971, Oct-02, Volume: 101, Issue:39

    Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Blood Protein Disorders; Child, Preschool; Chloramphenicol; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Drug Synergism; Female; Hepatitis; Humans; Immunosuppressive Agents; Long-Term Care; Lupus Vulgaris; Male; Methotrexate; Middle Aged; Nephrosis, Lipoid; Pemphigus; Polyarteritis Nodosa; Postoperative Complications; Purpura, Thrombocytopenic; Scleroderma, Systemic; Transplantation, Homologous

1971